Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

AUG 01, 2015 - TheStreet

A Must Read - Share

Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'

NEW YORK ( TheStreet) -- Jim Cramer, portfolio manager at Action Alerts PLUS, and Jack Mohr, its research director, sat down to talk about Allergan -- their "favorite company in the portfolio." Allergan made headlines this week after the pharmaceutical company sold off its generics business to the Israeli Teva Pharmaceuticals in a "transformative" deal that totaled $40.5 billion.  Cramer knows ...

Tags: Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible',  Amgen Latest News

AUG 01, 2015 - TheStreet

A Must Read - Share

'Fast Money' Recap: Goodbye, July; Will August Be More of the Same?

NEW YORK (TheStreet) -- It was a hectic month for investors and August isn't shaping up to be any different. Over the past five years, the S&P 500 has declined by an average of 2.5% during August. On Friday, the index slid just 0.2%, while bonds rallied on the day.  On CNBC's "Fast Money" TV show, Guy Adami, managing director of stockmonster.com, ...

Tags: 'Fast Money' Recap: Goodbye, July; Will August Be More of the Same?,  Amgen Latest News

JUL 31, 2015 - ABC News

A Must Read - Share

LinkedIn and Expedia Are Big Market Movers

LinkedIn, Expedia, Hanesbrands, Amgen and Moneygram are big market movers

Tags: LinkedIn and Expedia Are Big Market Movers,  Amgen Latest News

JUL 31, 2015 - TheStreet

A Must Read - Share

Oil Skidded 21% During July--and Was a Big Drag on Stocks

NEW YORK (TheStreet) -- July was a mixed month for markets as the S&P 500 and Nasdaq closed with slight gains, while the Dow Jones Industrial Average saw a loss.  For the month, the S&P 500 added 1.2% and the Nasdaq gained 1%. The Dow lost 0.4%. Must Read: Warren Buffett's Top 10 Dividend Stocks But none suffered more this month than ...

Tags: Oil Skidded 21% During July--and Was a Big Drag on Stocks,  Amgen Latest News

JUL 31, 2015 - TheStreet

A Must Read - Share

Amgen (AMGN) Stock Higher as Barclays Increases Price Target

NEW YORK (TheStreet) -- Amgen price target was raised to $185 from $180 at Barclays, which maintained its "equal weight" rating. The firm also increased 2015 earnings estimates to $9.70 from $9.46, with 2016 earnings estimates raised to $10.75 from $10.47. Amgen reported its 2015 second quarter financial results yesterday with earnings of $2.57 per share on revenue of $5.37 ...

Tags: Amgen (AMGN) Stock Higher as Barclays Increases Price Target,  Amgen Latest News